THE EFFECT OF GONADAL-STEROIDS ON VASOACTIVE-INTESTINAL-PEPTIDE CONCENTRATION AND RELEASE FROM MEDIOBASAL HYPOTHALAMUS AND THE ANTERIOR-PITUITARY GLAND

被引:11
作者
LASAGA, M
DUVILANSKI, BH
SEILICOVICH, A
AFIONE, S
DIAZ, MD
PISERA, D
TRAKTENBERG, R
DEBELJUK, L
机构
[1] Centre de Investigaciones en Reproduction, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires
关键词
GONADAL STEROIDS; VASOACTIVE INTESTINAL PEPTIDE CONTENT; VASOACTIVE INTESTINAL PEPTIDE RELEASE; MEDIOBASAL HYPOTHALAMUS; ANTERIOR PITUITARY;
D O I
10.1111/j.1365-2826.1991.tb00242.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of chronic administration of sex steroids on the content of vasoactive intestinal peptide (VIP) in the mediobasal hypothalamus and anterior pituitary were studied in adult rats. Gonadectomy had no effect on VIP concentration in the mediobasal hypothalamus or anterior pituitary gland. Estradiol benzoate (1-mu-g/100 g body wt/day) administered for 10 days decreased mediobasal hypothalamus VIP concentration of ovariectomized rats whereas it produced no change in mediobasal hypothalamus VIP content of orchidectomized rats. Testosterone propionate (100-mu-g/100 g body wt/day) administration decreased mediobasal hypothalamus VIP content in both sexes. Estradiol administration caused an increase whereas testosterone treatment resulted in a decrease in anterior pituitary VIP levels in both sexes. The effect of chronic administration of the sex steroids on VIP release from the mediobasal hypothalamus and anterior pituitary was also investigated. Estradiol increased evoked VIP release from the mediobasal hypothalamus and decreased mediobasal hypothalamus VIP content whereas testosterone decreased both mediobasal hypothalamus release and content. Chronic treatment with estradiol enhanced anterior pituitary VIP release and content while testosterone decreased both parameters studied. The data indicate that anterior pituitary VIP content is under the control of gonadal hormones and that the increased anterior pituitary VIP found after estradiol administration may be due to an augmented release from the mediobasal hypothalamus and probably an increase in anterior pituitary VIP synthesis.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 29 条
[1]   VASOACTIVE INTESTINAL PEPTIDE IS A PHYSIOLOGICAL MEDIATOR OF PROLACTIN-RELEASE IN THE RAT [J].
ABE, H ;
ENGLER, D ;
MOLITCH, ME ;
BOLLINGERGRUBER, J ;
REICHLIN, S .
ENDOCRINOLOGY, 1985, 116 (04) :1383-1390
[2]   VASOACTIVE INTESTINAL POLYPEPTIDE IS SYNTHESIZED IN ANTERIOR-PITUITARY TISSUE [J].
ARNAOUT, MA ;
GARTHWAITE, TL ;
MARTINSON, DR ;
HAGEN, TC .
ENDOCRINOLOGY, 1986, 119 (05) :2052-2057
[3]  
BATAILLE D, 1979, CR HEBD ACAD SCI, V188, P1315
[4]   VASOACTIVE INTESTINAL PEPTIDE (VIP) - BRAIN DISTRIBUTION, SUBCELLULAR-LOCALIZATION AND EFFECT OF DEAFFERENTATION OF THE HYPOTHALAMUS IN MALE-RATS [J].
BESSON, J ;
ROTSZTEJN, W ;
LABURTHE, M ;
EPELBAUM, J ;
BEAUDET, A ;
KORDON, C ;
ROSSELIN, G .
BRAIN RESEARCH, 1979, 165 (01) :79-85
[5]   EFFECT OF PROLACTIN AND ESTRADIOL ON RAT STRIATAL DOPAMINE-RECEPTORS [J].
DIPAOLO, T ;
POYET, P ;
LABRIE, F .
LIFE SCIENCES, 1982, 31 (25) :2921-2929
[6]   VASOACTIVE-INTESTINAL-PEPTIDE AFFECTS THE GABAERGIC SYSTEM IN THE HYPOTHALAMIC-PITUITARY AXIS [J].
DUVILANSKI, BH ;
LASAGA, M ;
SEILICOVICH, A ;
AFIONE, S ;
DIAZ, MD ;
DEBELJUK, L .
BRAIN RESEARCH BULLETIN, 1990, 25 (02) :215-219
[7]   STIMULATION OF INVITRO PROLACTIN-RELEASE BY VASOACTIVE INTESTINAL PEPTIDE [J].
ENJALBERT, A ;
ARANCIBIA, S ;
RUBERG, M ;
PRIAM, M ;
BLUETPAJOT, MT ;
ROTSZTEJN, WH ;
KORDON, C .
NEUROENDOCRINOLOGY, 1980, 31 (03) :200-204
[8]  
GARTHWAITE TL, 1987, 69TH P ANN M END SOC
[9]   ALTERATIONS IN CENTRAL NEUROTRANSMITTER RECEPTOR-BINDING SITES FOLLOWING ESTRADIOL IMPLANTATION IN FEMALE RATS [J].
GOETZ, C ;
BOURGOIN, S ;
CESSELIN, F ;
BRANDI, A ;
BRESSION, D ;
MARTINET, M ;
PEILLON, F ;
HAMON, M .
NEUROCHEMISTRY INTERNATIONAL, 1983, 5 (04) :375-383
[10]   LACTATION ELEVATES VASOACTIVE INTESTINAL PEPTIDE MESSENGER RIBONUCLEIC-ACID IN RAT SUPRACHIASMATIC NUCLEUS [J].
GOZES, I ;
AVIDOR, R ;
BIEGON, A ;
BALDINO, F .
ENDOCRINOLOGY, 1989, 124 (01) :181-186